Literature DB >> 6272159

Development of central control of norepinephrine turnover and release in the rat heart: responses to tyramine, 2-deoxyglucose and hydralazine.

F J Seidler, T A Slotkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272159     DOI: 10.1016/0306-4522(81)90047-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


× No keyword cloud information.
  7 in total

1.  Terbutaline impairs the development of peripheral noradrenergic projections: potential implications for autism spectrum disorders and pharmacotherapy of preterm labor.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2012-07-16       Impact factor: 3.763

2.  Developmental neurotoxicity targeting hepatic and cardiac sympathetic innervation: effects of organophosphates are distinct from those of glucocorticoids.

Authors:  Frederic J Seidler; Theodore A Slotkin
Journal:  Brain Res Bull       Date:  2011-03-29       Impact factor: 4.077

3.  Mimicking maternal smoking and pharmacotherapy of preterm labor: fetal nicotine exposure enhances the effect of late gestational dexamethasone treatment on noradrenergic circuits.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2011-08-19       Impact factor: 4.077

4.  Adolescents and adults differ in the immediate and long-term impact of nicotine administration and withdrawal on cardiac norepinephrine.

Authors:  Theodore A Slotkin; Ashley Stadler; Samantha Skavicus; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2016-03-15       Impact factor: 4.077

5.  Prenatal drug exposures sensitize noradrenergic circuits to subsequent disruption by chlorpyrifos.

Authors:  Theodore A Slotkin; Samantha Skavicus; Frederic J Seidler
Journal:  Toxicology       Date:  2015-09-28       Impact factor: 4.221

6.  Adrenomedullary function in the neonatal rat: responses to acute hypoxia.

Authors:  F J Seidler; T A Slotkin
Journal:  J Physiol       Date:  1985-01       Impact factor: 5.182

7.  Does growth impairment underlie the adverse effects of dexamethasone on development of noradrenergic systems?

Authors:  Theodore A Slotkin; Ashley Ko; Frederic J Seidler
Journal:  Toxicology       Date:  2018-06-20       Impact factor: 4.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.